Bejerano, Jerry A.

HRN: 20-24-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
CEFTRIAXONE 1G (VIAL)
05/18/2023
05/24/2023
IVT
2g
OD
UTI
Waiting Final Action 
05/19/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/19/2023
05/24/2023
PO
1 Tab
OD
T/c CAP-MR
Waiting Final Action 
07/08/2023
CEFTAZIDIME 1GM (VIAL)
07/08/2023
07/14/2023
IVT
1g
Q8
Septic Arthritis
Waiting Final Action 
07/08/2023
MUPIROCIN 2%, 15G (TUBE)
07/08/2023
07/14/2023
TOPICAL
2%
BID
Bed Sores
Waiting Final Action 
07/08/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2023
07/14/2023
IVT
2.25g
Q6
Septic Arthritis
Waiting Final Action 
07/17/2023
MUPIROCIN 2%, 15G (TUBE)
07/17/2023
07/24/2023
TOPICAL
Sufficient Amount
BID
Decubitus Ulcer
Waiting Final Action 
07/18/2023
MUPIROCIN 2%, 15G (TUBE)
07/18/2023
07/25/2023
TOPICAL
BID Application
OD
Decubitus Ulcer
Waiting Final Action 
10/25/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/25/2023
11/01/2023
IV
1.5
Q8
Decubitus Ulcer
Waiting Final Action 
10/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/25/2023
11/01/2023
IV
500
Q8
Decubitus Ulcer
Waiting Final Action 
10/26/2023
MUPIROCIN 2%, 15G (TUBE)
10/26/2023
11/01/2023
TOPICAL
2%
BID
DECUBITUS ULCER
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: